Literature DB >> 20924103

Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement.

Rebecca A Whipple1, Michael A Matrone, Edward H Cho, Eric M Balzer, Michele I Vitolo, Jennifer R Yoon, Olga B Ioffe, Kimberly C Tuttle, Jing Yang, Stuart S Martin.   

Abstract

Epithelial-to-mesenchymal transition (EMT) is associated with increased breast tumor metastasis; however, the specific mechanisms by which EMT promotes metastasis remain somewhat unclear. Despite the importance of cytoskeletal dynamics during both EMT and metastasis, very few current studies examine the cytoskeleton of detached and circulating tumor cells. Specific posttranslational α-tubulin modifications are critical for adherent cell motility and implicated in numerous pathologies, but also remain understudied in detached cells. We report here that EMT induced through ectopic expression of Twist or Snail promotes α-tubulin detyrosination and the formation of tubulin-based microtentacles in detached HMLEs. Mechanistically, EMT downregulates the tubulin tyrosine ligase enzyme, resulting in an accumulation of detyrosinated α-tubulin (Glu-tubulin), and increases microtentacles that penetrate endothelial layers to facilitate tumor cell reattachment. Confocal microscopy shows that microtentacles are capable of penetrating the junctions between endothelial cells. Suppression of endogenous Twist in metastatic human breast tumor cells is capable of reducing both tubulin detyrosination and microtentacles. Clinical breast tumor samples display high concordance between Glu-tubulin and Twist expression levels, emphasizing the coupling between EMT and tubulin detyrosination in vivo. Coordinated elevation of Twist and Glu-tubulin at invasive tumor fronts, particularly within ductal carcinoma in situ samples, establishes that EMT-induced tubulin detyrosination occurs at the earliest stages of tumor invasion. These data support a novel model where the EMT that occurs during tumor invasion downregulates tubulin tyrosine ligase, increasing α-tubulin detyrosination and promoting microtentacles that could enhance the reattachment of circulating tumor cells to the vascular endothelium during metastasis. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20924103      PMCID: PMC3123454          DOI: 10.1158/0008-5472.CAN-09-4613

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

Review 1.  The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it.

Authors:  Elizabeth D Hay
Journal:  Dev Dyn       Date:  2005-07       Impact factor: 3.780

Review 2.  An overview of epithelio-mesenchymal transformation.

Authors:  E D Hay
Journal:  Acta Anat (Basel)       Date:  1995

3.  Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence.

Authors:  Jochen Guck; Stefan Schinkinger; Bryan Lincoln; Falk Wottawah; Susanne Ebert; Maren Romeyke; Dominik Lenz; Harold M Erickson; Revathi Ananthakrishnan; Daniel Mitchell; Josef Käs; Sydney Ulvick; Curt Bilby
Journal:  Biophys J       Date:  2005-02-18       Impact factor: 4.033

4.  Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target.

Authors:  Wai Kei Kwok; Ming-Tat Ling; Tak-Wing Lee; Tracy C M Lau; Chun Zhou; Xiaomeng Zhang; Chee Wai Chua; Kwok W Chan; Franky L Chan; Carlotta Glackin; Yong-Chuan Wong; Xianghong Wang
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

5.  Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells.

Authors:  M A Matrone; R A Whipple; K Thompson; E H Cho; M I Vitolo; E M Balzer; J R Yoon; O B Ioffe; K C Tuttle; M Tan; S S Martin
Journal:  Oncogene       Date:  2010-03-15       Impact factor: 9.867

6.  Regulation of cytoplasmic tubulin carboxypeptidase activity during neural and muscle differentiation: characterization using a microtubule-based assay.

Authors:  D R Webster; N M Modesti; J C Bulinski
Journal:  Biochemistry       Date:  1992-06-30       Impact factor: 3.162

7.  Normal and prostate cancer cells display distinct molecular profiles of alpha-tubulin posttranslational modifications.

Authors:  Karel Soucek; Andrés Kamaid; Anh D Phung; Lukás Kubala; J Chloë Bulinski; Richart W Harper; Jason P Eiserich
Journal:  Prostate       Date:  2006-06-15       Impact factor: 4.104

8.  Invadopodia and podosomes in tumor invasion.

Authors:  Hideki Yamaguchi; Fiona Pixley; John Condeelis
Journal:  Eur J Cell Biol       Date:  2005-11-08       Impact factor: 4.492

9.  Suppression of tubulin tyrosine ligase during tumor growth.

Authors:  L Lafanechère; C Courtay-Cahen; T Kawakami; M Jacrot; M Rüdiger; J Wehland; D Job; R L Margolis
Journal:  J Cell Sci       Date:  1998-01       Impact factor: 5.285

10.  Generation of a stable, posttranslationally modified microtubule array is an early event in myogenic differentiation.

Authors:  G G Gundersen; S Khawaja; J C Bulinski
Journal:  J Cell Biol       Date:  1989-11       Impact factor: 10.539

View more
  63 in total

1.  Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression.

Authors:  B O Sun; Yantian Fang; Zhenyang Li; Zongyou Chen; Jianbin Xiang
Journal:  Biomed Rep       Date:  2015-07-27

2.  A real-time electrical impedance based technique to measure invasion of endothelial cell monolayer by cancer cells.

Authors:  Said Rahim; Aykut Üren
Journal:  J Vis Exp       Date:  2011-04-01       Impact factor: 1.355

3.  Glu-tubulin is a marker for Schwann cells and can distinguish between schwannomas and neurofibromas.

Authors:  Josune García-Sanmartín; Susana Rubio-Mediavilla; José J Sola-Gallego; Alfredo Martínez
Journal:  Histochem Cell Biol       Date:  2016-06-09       Impact factor: 4.304

4.  Regulation of epithelial to mesenchymal transition: CK2β on stage.

Authors:  Alexandre Deshiere; Eve Duchemin-Pelletier; Elodie Spreux; Delphine Ciais; Christelle Forcet; Claude Cochet; Odile Filhol
Journal:  Mol Cell Biochem       Date:  2011-07-14       Impact factor: 3.396

Review 5.  The chemical complexity of cellular microtubules: tubulin post-translational modification enzymes and their roles in tuning microtubule functions.

Authors:  Christopher P Garnham; Antonina Roll-Mecak
Journal:  Cytoskeleton (Hoboken)       Date:  2012-04-26

Review 6.  Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer.

Authors:  E S Antonarakis; A J Armstrong
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-05-17       Impact factor: 5.554

7.  Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis.

Authors:  Marco Chilosi; Anna Caliò; Andrea Rossi; Eliana Gilioli; Federica Pedica; Licia Montagna; Serena Pedron; Marco Confalonieri; Claudio Doglioni; Rolf Ziesche; Markus Grubinger; Wolfgang Mikulits; Venerino Poletti
Journal:  Mod Pathol       Date:  2016-09-02       Impact factor: 7.842

Review 8.  Molecular Pathways: New Signaling Considerations When Targeting Cytoskeletal Balance to Reduce Tumor Growth.

Authors:  Kristi R Chakrabarti; Lindsay Hessler; Lekhana Bhandary; Stuart S Martin
Journal:  Clin Cancer Res       Date:  2015-10-13       Impact factor: 12.531

9.  Cytoskeletal organization in microtentacles.

Authors:  Alison N Killilea; Roseann Csencsits; Emily Bao Ngoc Thien Le; Anand M Patel; Samuel J Kenny; Ke Xu; Kenneth H Downing
Journal:  Exp Cell Res       Date:  2017-05-25       Impact factor: 3.905

10.  Partial thermal imidization of polyelectrolyte multilayer cell tethering surfaces (TetherChip) enables efficient cell capture and microtentacle fixation for circulating tumor cell analysis.

Authors:  Julia A Ju; Cornell J Lee; Keyata N Thompson; Eleanor C Ory; Rachel M Lee; Trevor J Mathias; Stephen J P Pratt; Michele I Vitolo; Christopher M Jewell; Stuart S Martin
Journal:  Lab Chip       Date:  2020-08-03       Impact factor: 6.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.